{"id":1901,"date":"2020-04-27T06:58:09","date_gmt":"2020-04-27T06:58:09","guid":{"rendered":"https:\/\/www.ccomsys.net\/million-dollar-idea\/?p=1901"},"modified":"2020-04-30T06:08:53","modified_gmt":"2020-04-30T06:08:53","slug":"the-silver-lining-for-pharma-companies-in-the-coronavirus-dark-clouds","status":"publish","type":"post","link":"https:\/\/www.ccomdigital.in\/blog\/the-silver-lining-for-pharma-companies-in-the-coronavirus-dark-clouds\/","title":{"rendered":"The Silver Lining For Pharma Companies In The Coronavirus Dark Clouds"},"content":{"rendered":"

The <\/span>\u2018Exit China\u2019<\/b> mantra is an open international secret now. As per some reports, more than 1000 firms are mulling shifting their production to India. The Union Minister of Road Transport and Highways and MSMEs Nitin Gadkari is estimating an investment of \u20b925 lac crores to come into India\u2019s manufacturing sector. Apart from manufacturing, we see a <\/span>thick silver lining for Indian pharmaceutical companies.<\/b><\/p>\n

Ever since the global financial crisis of 2008, the world had been blinded by consumption. The world added thousands of McDonalds, Starbucks, hotel rooms and flights but it hasn\u2019t added many hospital rooms. The world has clearly failed to plan against a pandemic and that has left all the countries highly vulnerable to Covid-19. But the world has also learnt its lessons and countries have become wiser. Hence, the next decade will belong to the growth of what we say the health infrastructure. This means addition of more hospital rooms, more ICU beds, introduction of new diagnostics and testing tools and most importantly new breakthroughs in vaccines & medicines. This outlook has resulted in many countries stressing on the necessity of low cost medicines for all diseases. With growing negative sentiments against China, Indian pharmaceutical companies can capture a huge portion of this pie. This is the silver lining that we are talking about.<\/span><\/p>\n

But there\u2019s a lot of groundwork that the Indian pharma companies need to complete, especially on <\/span>Digital Marketing<\/b>. The Indian pharmaceutical companies, weighed down by the strict guidelines, have never prioritised the need for digital marketing, be it for their markets in India or internationally. Now in a post coronavirus world, which is digital first, Indian pharma companies will have to ensure that they score high in the digital world by way of:<\/span><\/p>\n